story of the week
Serial ctDNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Use of Serial Circulating Tumor DNA (ctDNA) to Detect Resistance Alterations in Progressive Metastatic Breast Cancer
Clin. Cancer Res 2020 Dec 15;[EPub Ahead of Print], S Jacob, AA Davis, L Gerratana, M Velimirovic, AN Shah, F Wehbe, N Katam, Q Zhang, L Flaum, KP Siziopikou, LC Platanias, W Gradishar, A Behdad, A Bardia, M CristofanilliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.